FDA Import Refusal AEK-8229764-7/141/1 — Intas Pharmaceuticals Limited
The FDA refused shipment AEK-8229764-7/141/1 from Intas Pharmaceuticals Limited (India) on Mar 4, 2025. The refused product falls under Drugs and Biologics — NAPHAZOLINE HCL (ADRENERGIC). Cited charges: 27,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Mar 4, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 60CDY46 NAPHAZOLINE HCL (ADRENERGIC)
- Charges
- 27,75